Sandu Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 764862, "name": "Sandu Pharma.", "stock_name": "Sandu Pharma.", "full_name": "Sandu Pharmaceuticals Ltd", "name_url": "stocks-analysis/sandu-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "37.00", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "37.00", "mcapval": "37.00 Cr", "mcap": "Micro Cap", "scripcode": 524703, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 49, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE751D01014", "curr_date": "Sep 25, 03:30 PM", "curr_time": "09:58 AM", "last_traded_at": "Sep 25, 03:30 PM IST", "bse_nse_vol": "1.62 k", "exc_status": "Active", "traded_date": "Sep 25, 2026", "traded_date_str": "2026 09 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sandu-pharma-764862-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sandu Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-sell-4171334", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_mojoScore_4171334.png", "date": "2026-08-27 10:11:02", "description": "Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Sandu Pharmaceuticals Declines 6.69%: Valuation and Technical Shifts Mark a Mixed Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-declines-669-valuation-and-technical-shifts-mark-a-mixed-week-4155702", "imagepath": "", "date": "2026-08-15 15:06:29", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> Stock opens at Rs.39.80, slight gain of 0.48%</p>\n <p><strong>11 Aug:</strong> Valuation metrics improve, rating upgraded to 'Sell'</p>\n <p><strong>12 Aug:</strong> Technical indicators show sideways momentum amid flat financials</p>\n <p><strong>13 Aug:</strong> Sharp price drop of 7.69% on heavy volume</p>\n <p><strong>14 Aug:</strong> Minor recovery with 1.90% gain, week closes at Rs.36.96</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.39.61</div></div>\n ..." }, { "title": "Sandu Pharmaceuticals Ltd Upgraded to Sell on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-upgraded-to-sell-on-technical-and-valuation-improvements-4149487", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_mojoScore_4149487.png", "date": "2026-08-12 08:15:21", "description": "Sandu Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in its technical outlook and valuation metrics despite ongoing fundamental challenges. The upgrade, effective from 11 August 2026, follows a detailed reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals." }, { "title": "Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4146177", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_valuationdot_4146177.png", "date": "2026-08-11 08:01:29", "description": "Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions amid mixed financial metrics and sector comparisons. This article analyses the recent changes in key valuation ratios, their implications for investors, and how Sandu Pharma stacks up against its peers and broader market benchmarks." }, { "title": "Sandu Pharmaceuticals Gains 1.46%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-gains-146-2-key-factors-driving-the-week-4143405", "imagepath": "", "date": "2026-08-08 15:10:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock surged 4.23% to Rs.40.69 on strong volume</p>\n <p><strong>5 Aug:</strong> Valuation metrics improved, signalling renewed price attractiveness</p>\n <p><strong>6 Aug:</strong> Stock declined 3.32% amid bearish technical signals</p>\n <p><strong>7 Aug:</strong> Downgrade to Strong Sell rating announced; stock closed at Rs.39.61 (+2.94%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.39.04</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</d..." }, { "title": "Sandu Pharmaceuticals Downgraded to Strong Sell Amid Technical and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-downgraded-to-strong-sell-amid-technical-and-financial-concerns-4141154", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_mojoScore_4141154.png", "date": "2026-08-07 08:12:27", "description": "Sandu Pharmaceuticals Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating technical indicators and persistent financial underperformance. Despite an attractive valuation, the company’s weak fundamentals and bearish technical trends have raised concerns among investors, prompting a reassessment of its market prospects." }, { "title": "Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4136832", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_valuationdot_4136832.png", "date": "2026-08-05 08:02:20", "description": "Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price attractiveness despite recent share price declines and mixed performance against benchmark indices. This article analyses the evolving valuation metrics, peer comparisons, and market returns to provide a comprehensive view for investors considering this micro-cap pharmaceutical player." }, { "title": "When is the next results date for Sandu Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sandu-pharmaceuticals-ltd-4136326", "imagepath": "", "date": "2026-08-04 23:18:24", "description": "The next results date for Sandu Pharmaceuticals Ltd is scheduled for 11 August 2026...." }, { "title": "Sandu Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-sell-4128375", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanduPharmaceut_mojoScore_4128375.png", "date": "2026-07-30 10:11:27", "description": "Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 117, "sid": "764862", "stock_news_url": "https://www.marketsmojo.com/news/sandu-pharmaceuticals-764862" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "22-Sep-2026", "details": "Intimation about closure of trading window for Quarter ended 30th September 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s", "datetime": "12-Sep-2026", "details": "Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate", "datetime": "12-Sep-2026", "details": "1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sandu Pharmaceuticals Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 26", "dt": "2026-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Stock surged 4.23% to Rs.40.69 on strong volume

5 Aug: Valuation metrics improved, signalling renewed price attractiveness

6 Aug: Stock declined 3.32% amid bearish technical signals

7 Aug: Downgrade to Strong Sell rating announced; stock closed at Rs.39.61 (+2.94%)

Week Open

Rs.39.04

Week CloseRead full news article

Sandu Pharmaceuticals Downgraded to Strong Sell Amid Technical and Financial Concerns

2026-08-07 08:12:27

Sandu Pharmaceuticals Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating technical indicators and persistent financial underperformance. Despite an attractive valuation, the company’s weak fundamentals and bearish technical trends have raised concerns among investors, prompting a reassessment of its market prospects.

Read full news article

Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-05 08:02:20

Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price attractiveness despite recent share price declines and mixed performance against benchmark indices. This article analyses the evolving valuation metrics, peer comparisons, and market returns to provide a comprehensive view for investors considering this micro-cap pharmaceutical player.

Read full news article

When is the next results date for Sandu Pharmaceuticals Ltd?

2026-08-04 23:18:24

The next results date for Sandu Pharmaceuticals Ltd is scheduled for 11 August 2026....

Read full news article

Sandu Pharmaceuticals Ltd is Rated Sell

2026-07-30 10:11:27

Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article